AAAAAA

   
Results: << | 201-225 | 226-250 | 251-275 | 276-300 | >>

Table of contents of journal: *Molecular medicine today (Regular ed.)

Results: 201-225/784

Authors: Dorrell, S
Citation: S. Dorrell, Blocking HIV-1 infection with intrakines, MOL MED TOD, 5(3), 1999, pp. 97-97

Authors: Brooksbank, C
Citation: C. Brooksbank, How much molecular medicine do medical students need to learn?, MOL MED TOD, 5(3), 1999, pp. 100-100

Authors: Papavassiliou, AG
Citation: Ag. Papavassiliou, Biochemistry versus molecular medicine: what should we be teaching our medical students?, MOL MED TOD, 5(3), 1999, pp. 100-101

Authors: Smith, HC Hundert, EM
Citation: Hc. Smith et Em. Hundert, Integrating molecular medicine into the medical school curriculum, MOL MED TOD, 5(3), 1999, pp. 102-103

Authors: Cox, TB
Citation: Tb. Cox, Medical education: catering for the carers as well as the innovators, MOL MED TOD, 5(3), 1999, pp. 103-104

Authors: Kelsell, DP Stevens, HP
Citation: Dp. Kelsell et Hp. Stevens, The palmoplantar keratodermas: much more than palms and soles, MOL MED TOD, 5(3), 1999, pp. 107-113

Authors: McKenzie, KE Umbricht, CB Sukumar, S
Citation: Ke. Mckenzie et al., Applications of telomerase research in the fight against cancer, MOL MED TOD, 5(3), 1999, pp. 114-122

Authors: Karima, R Matsumoto, S Higashi, H Matsushima, K
Citation: R. Karima et al., The molecular pathogenesis of endotoxic shock and organ failure, MOL MED TOD, 5(3), 1999, pp. 123-132

Authors: Baylink, DJ Strong, DD Mohan, S
Citation: Dj. Baylink et al., The diagnosis and treatment of osteoporosis: future prospects, MOL MED TOD, 5(3), 1999, pp. 133-140

Authors: Senior, K
Citation: K. Senior, Human embryonic stem cells: the future of transplantation medicine?, MOL MED TOD, 5(2), 1999, pp. 47-48

Authors: Bonn, D
Citation: D. Bonn, Targeting protein breakdown to treat cancer, MOL MED TOD, 5(2), 1999, pp. 48-49

Authors: Dorrell, S
Citation: S. Dorrell, Virus buster for transfusion blood, MOL MED TOD, 5(2), 1999, pp. 49-50

Authors: Fricker, J
Citation: J. Fricker, Turning off RB for a healthy heart?, MOL MED TOD, 5(2), 1999, pp. 50-51

Authors: Walsh, K Sata, M
Citation: K. Walsh et M. Sata, Is extravasation a Fas-regulated process?, MOL MED TOD, 5(2), 1999, pp. 61-67

Authors: Canick, JA Kellner, LH Cole, LA Cuckle, HS
Citation: Ja. Canick et al., Urinary analyte screening: a noninvasive detection method for Down syndrome?, MOL MED TOD, 5(2), 1999, pp. 68-73

Authors: Artlett, CM Smith, JB Jimenez, SA
Citation: Cm. Artlett et al., New perspectives on the etiology of systemic sclerosis, MOL MED TOD, 5(2), 1999, pp. 74-78

Authors: Inui, A
Citation: A. Inui, Neuropeptide Y: a key molecule in anorexia and cachexia in wasting disorders?, MOL MED TOD, 5(2), 1999, pp. 79-85

Authors: van Steeg, H Kraemer, KH
Citation: H. Van Steeg et Kh. Kraemer, Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer, MOL MED TOD, 5(2), 1999, pp. 86-94

Authors: Habeck, M
Citation: M. Habeck, Gelsolin: a new marker for breast cancer?, MOL MED TOD, 5(12), 1999, pp. 503-503

Authors: Sansom, C
Citation: C. Sansom, Mice illuminate the pathways to lupus, MOL MED TOD, 5(12), 1999, pp. 504-505

Authors: Fricker, J
Citation: J. Fricker, Heart disease linked to oestrogen-receptor gene methylation, MOL MED TOD, 5(12), 1999, pp. 505-506

Authors: Senior, K
Citation: K. Senior, The complex puzzle of gene variation and essential hypertension, MOL MED TOD, 5(12), 1999, pp. 506-506

Authors: Hardy, J Gwinn-Hardy, K
Citation: J. Hardy et K. Gwinn-hardy, Neurodegenerative disease: a different view of diagnosis, MOL MED TOD, 5(12), 1999, pp. 514-517

Authors: Acton, SL Kozarsky, KF Rigotti, A
Citation: Sl. Acton et al., The HDL receptor SR-BI: a new therapeutic target for atherosclerosis?, MOL MED TOD, 5(12), 1999, pp. 518-524

Authors: Yenari, MA Giffard, RG Sapolsky, RM Steinberg, GK
Citation: Ma. Yenari et al., The neuroprotective potential of heat shock protein 70 (HSP70), MOL MED TOD, 5(12), 1999, pp. 525-531
Risultati: << | 201-225 | 226-250 | 251-275 | 276-300 | >>